Product image of Metypred (Methylprednisolone) supplied by GNH India

Metypred

Active Ingredient:
Methylprednisolone
Origin:
EU

Metypred (Methylprednisolone)

Methylprednisolone, the active ingredient in Metypred, is a glucocorticoid presented as an oral tablet for systemic use. It reduces inflammation and modulates immune responses, making it useful in a range of inflammatory, autoimmune and allergic conditions across adult and pediatric populations.

GNH India supplies Metypred as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, providing consistent quality and regulatory compliance for bulk and packaged orders. The product meets EU pharmacopeial standards and is manufactured under GMP conditions.

Manufacturer / TM Owner

Orion Corporation

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methylprednisolone is a systemic glucocorticoid used to manage inflammatory and immune‑mediated conditions.

  • Rheumatoid arthritis: reduces joint inflammation and pain, improving mobility.
  • Asthma exacerbations: suppresses airway inflammation to restore breathing function.
  • Severe eczema (autoimmune dermatitis): diminishes skin inflammation and pruritus.
  • Acute allergic reactions: attenuates hypersensitivity responses and swelling.

How It Works

  • Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action up‑regulates anti‑inflammatory proteins and down‑regulates pro‑inflammatory cytokines, leading to reduced leukocyte migration, decreased capillary permeability, and overall suppression of immune activity.

Side Effects

Methylprednisolone may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

  • Increased appetite and weight gain.
  • Insomnia or mood changes.
  • Elevated blood glucose levels.
  • Gastrointestinal discomfort or dyspepsia.
  • Fluid retention causing mild edema.

Serious or Rare Side Effects

  • Adrenal insufficiency with abrupt discontinuation.
  • Severe infections due to immunosuppression.
  • Osteoporosis and increased fracture risk.
  • Cataracts or glaucoma.
  • Psychosis or severe mood disturbances.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate individual risk factors and monitor patients regularly.

  • Assess infection risk: screen for active infections prior to treatment.
  • Monitor blood glucose: adjust diabetic therapy as needed.
  • Evaluate bone health: consider calcium and vitamin D supplementation.
  • Use lowest effective dose: limit duration to reduce systemic effects.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Methylprednisolone can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure.
  • Live vaccines: heightened risk of uncontrolled infection.
  • Anticoagulants (e.g., warfarin): enhanced anticoagulant effect.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs: increased gastrointestinal risk.
  • Diabetes medications: may require dose adjustment due to hyperglycaemia.
  • Inactivated vaccines: possible reduced immunogenic response.

Frequently Asked Questions

Metypred contains methylprednisolone, a glucocorticoid that is prescribed for inflammatory and immune‑mediated disorders such as rheumatoid arthritis, severe asthma attacks, autoimmune skin conditions, and acute allergic reactions. It works by dampening the body’s inflammatory response.

Methylprednisolone binds to intracellular glucocorticoid receptors, altering gene transcription. This increases production of anti‑inflammatory proteins while suppressing pro‑inflammatory cytokines, leading to reduced leukocyte activity, decreased capillary permeability, and overall immunosuppression.

The dosage of Metypred is determined by the prescribing clinician based on the specific condition, severity, patient age, and response to therapy. Only a qualified healthcare professional should set the dose and duration.

Safety data for methylprednisolone in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the Metypred product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metypred (methylprednisolone) is a medium‑potency glucocorticoid with a relatively rapid onset of action. Compared with prednisone, it often provides stronger anti‑inflammatory effects at equivalent doses, while having a similar safety profile when used appropriately.

Metypred should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, direct sunlight, and excessive heat to maintain potency.

Metypred is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their prescriber to ensure optimal absorption.

Serious risks include adrenal insufficiency if the drug is stopped abruptly, severe infections due to immunosuppression, osteoporosis with long‑term use, and potential psychiatric effects such as mood swings or psychosis. Patients should be monitored closely for these events.

Metypred is contraindicated in patients with known hypersensitivity to methylprednisolone or any component of the formulation, uncontrolled systemic fungal infections, and those receiving live vaccines. Caution is also advised in patients with uncontrolled diabetes, severe hypertension, or active peptic ulcer disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT